Stock LYTIX LYTIX BIOPHARMA
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Lytix Biopharma

Equities

LYTIX

NO0010405780

Real-time Oslo Bors
Other stock markets
 07:48:57 2024-06-11 am EDT 		5-day change 1st Jan Change
7 NOK -0.57% Intraday chart for Lytix Biopharma +1.45% +44.03%
May. 30 Transcript : Lytix Biopharma AS, Q1 2024 Earnings Call, May 30, 2024
May. 30 Lytix Biopharma AS Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Lytix Biopharma Elects New Chair
MT
Lytix Biopharma AS Appoints Marie Ann Roskrow as New Chairman of the Board
CI
Norway's Lytix Biopharma Appoints Chief Business Officer
MT
Lytix Biopharma AS Appoints Stephen Worsley as Chief Business Officer
CI
Lytix Biopharma AS Announces Board Changes
CI
Lytix Biopharma Appoints Andrew Saunders as Chief Medical Officer, Effective of January 19, 2015
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LYTIX Stock
  4. News Lytix Biopharma
  5. Insiders